Position in BMY
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$7,853,548
+$993,912 QoQ
Shares Held
136,299
+20.5% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.32%
of 13F equity value
Holder Rank
#434
of 2,506 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Banque Cantonale Vaudoise holds $123,482,590 across 10 Drug Manufacturers - General names. BMY ranks #7 (6.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
21,866 | $26,226,738 | |
| 2 | JNJ |
Johnson & Johnson
|
90,804 | $23,061,491 | |
| 3 | ABBV |
AbbVie Inc.
|
89,306 | $22,472,961 | |
| 4 | MRK |
Merck & Co., Inc.
|
105,147 | $13,511,389 | |
| 5 | AZN |
Astrazeneca PLC
|
60,462 | $11,464,804 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
63,781 | $8,058,091 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
136,299 | $7,853,548 | |
| 8 | PFE |
Pfizer Inc
|
286,435 | $6,897,354 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,853,548 | 136,299 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $6,859,636 | 113,102 | Shares | Sole | 2026-04-20 | |
| 2025-12-31 | $5,531,385 | 102,547 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $5,762,517 | 127,772 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,694,963 | 101,425 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $11,383,722 | 186,649 | Shares | Sole | 2025-05-08 | |
| 2024-09-30 | $8,357,148 | 161,522 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $6,908,598 | 166,352 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $7,858,415 | 144,909 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $5,502,792 | 107,246 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $7,005,892 | 120,708 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,088,332 | 126,479 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $8,018,820 | 115,695 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $7,702,967 | 107,060 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $5,531,583 | 77,811 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $6,914,215 | 89,795 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $5,342,217 | 73,151 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $4,058,486 | 65,092 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $4,030,719 | 68,121 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $4,500,861 | 67,358 | Shares | Sole | 2021-08-11 | |
| 2021-03-31 | $4,322,574 | 68,471 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $4,295,887 | 69,255 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $4,878,907 | 80,924 | Shares | Sole | 2020-10-30 | |
| 2020-06-30 | $5,244,372 | 89,190 | Shares | Sole | 2020-07-22 | |
| 2020-03-31 | $2,664,093 | 47,795 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||